PAK 2 is an effector of TSC 1 / 2 signaling independent of mTOR and a potential therapeutic target for Tuberous Sclerosis Complex
暂无分享,去创建一个
E. Aronica | M. Peppelenbosch | C. Spek | J. Anink | M. Bruno | G. Fuhler | M. Nellist | K. Queiroz | Y. Elgersma | J. Scholma | M. Alves | M. Hoogeveen‐Westerveld | S. Goorden